Longitudinal effects of dimethyl fumarate on patient-reported outcome measures in multiple sclerosis: treatment satisfaction, quality of life, depressive symptoms, sleep, and work productivity

Key Points

• Improved patient-reported outcomes reflect enhanced treatment satisfaction over time.
• Quality of life scores increased significantly while depressive symptoms decreased among patients receiving dimethyl fumarate.
• Analysis using longitudinal data highlights changes in work productivity and sleep quality during treatment.
• Results support ongoing use of dimethyl fumarate for managing multiple sclerosis symptoms, indicating a favorable treatment profile.